Literature DB >> 12818433

FoxP4, a novel forkhead transcription factor.

Andreas Teufel1, Eric A Wong, Mahua Mukhopadhyay, Nasir Malik, Heiner Westphal.   

Abstract

Forkhead proteins have been demonstrated to play key roles in embryonic development, cell cycle regulation, and oncogenesis. We report the characterization of a new forkhead transcription factor, which is a member of the FoxP subfamily. In adult tissues FoxP4 is expressed in heart, brain, lung, liver, kidney, and testis. By Northern hybridization, very low levels of FoxP4 expression were found as early as E7 during embryonic development. Embryonic expression was highest at E11 and subsequently decreased at E15 and E17. In situ hybridization revealed expression of FoxP4 in the developing lung and gut, suggesting a role for FoxP4 during the development of these organs. In addition, FoxP4 was found to be significantly reduced in patients with kidney tumors. Lastly, FoxP4 matches an uncharacterized human EST that has previously been shown to be down-regulated in larynx carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12818433     DOI: 10.1016/s0167-4781(03)00074-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  31 in total

1.  The FOXP1 transcription factor is expressed in the majority of follicular lymphomas but is rarely expressed in classical and lymphocyte predominant Hodgkin's lymphoma.

Authors:  Philip Brown; Teresa Marafioti; Rajko Kusec; Alison H Banham
Journal:  J Mol Histol       Date:  2005-05       Impact factor: 2.611

2.  Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.

Authors:  Ryo Takata; Shusuke Akamatsu; Michiaki Kubo; Atsushi Takahashi; Naoya Hosono; Takahisa Kawaguchi; Tatsuhiko Tsunoda; Johji Inazawa; Naoyuki Kamatani; Osamu Ogawa; Tomoaki Fujioka; Yusuke Nakamura; Hidewaki Nakagawa
Journal:  Nat Genet       Date:  2010-08-01       Impact factor: 38.330

3.  FOXP4 modulates tumor growth and independently associates with miR-138 in non-small cell lung cancer cells.

Authors:  Tian Yang; Hong Li; Asmitananda Thakur; Tianjun Chen; Jing Xue; Dan Li; Mingwei Chen
Journal:  Tumour Biol       Date:  2015-05-21

4.  Up-regulation of microRNA-491-5p suppresses cell proliferation and promotes apoptosis by targeting FOXP4 in human osteosarcoma.

Authors:  Zhixun Yin; Hongmei Ding; Erxing He; Jingchen Chen; Ming Li
Journal:  Cell Prolif       Date:  2016-10-05       Impact factor: 6.831

5.  Downregulation of FOXP2 promoter human hepatocellular carcinoma cell invasion.

Authors:  Xia Yan; Huiling Zhou; Tingting Zhang; Pan Xu; Shusen Zhang; Wei Huang; Linlin Yang; Xingxing Gu; Runzhou Ni; Tianyi Zhang
Journal:  Tumour Biol       Date:  2015-07-06

6.  MiR-3196, a p53-responsive microRNA, functions as a tumor suppressor in hepatocellular carcinoma by targeting FOXP4.

Authors:  Wenjing Qi; Chengshun Gao; Li Zhang; Zhenming Gao; Jidong Sui; Chuanchun Han; Deguang Sun
Journal:  Am J Cancer Res       Date:  2019-12-01       Impact factor: 6.166

7.  Cancer as the Disintegration of Robustness: Population-Level Variance in Gene Expression Identifies Key Differences Between Tobacco- and HPV-Associated Oropharyngeal Carcinogenesis.

Authors:  Miriam M Ben-Dayan; Thomas MacCarthy; Nicolas F Schlecht; Thomas J Belbin; Geoffrey Childs; Richard V Smith; Michael B Prystowsky; Aviv Bergman
Journal:  Arch Pathol Lab Med       Date:  2015-07-01       Impact factor: 5.534

Review 8.  Forkhead box proteins: tuning forks for transcriptional harmony.

Authors:  Eric W-F Lam; Jan J Brosens; Ana R Gomes; Chuay-Yeng Koo
Journal:  Nat Rev Cancer       Date:  2013-07       Impact factor: 60.716

9.  MicroRNA-376a regulates cell proliferation and apoptosis by targeting forkhead box protein P2 in lymphoma.

Authors:  Shuna Yao; Yanyan Liu; Zhihua Yao; Yan Zhao; Haiying Wang; Yuanlin Xu; Jiuyang Zhang; Jing Li; Shujun Yang
Journal:  Oncol Lett       Date:  2018-06-22       Impact factor: 2.967

Review 10.  FOXP1: a potential therapeutic target in cancer.

Authors:  Henry B Koon; Gregory C Ippolito; Alison H Banham; Philip W Tucker
Journal:  Expert Opin Ther Targets       Date:  2007-07       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.